AmbuCineView: Evaluation of Immersive Audiovisual Distraction Impact on Peroperative Opioid Consumption.

Sponsor
University Hospital, Caen (Other)
Overall Status
Completed
CT.gov ID
NCT04238572
Collaborator
(none)
200
1
2
10.4
19.2

Study Details

Study Description

Brief Summary

This study evaluate the impact of an audiovisual distraction device on the peroperative opioid consumption for outpatient procedures with Remifentanil added to local anesthesia.

Half of patients will receive an audiovisual distraction device while the other half not.

Condition or Disease Intervention/Treatment Phase
  • Device: Audiovisual distraction device
  • Device: Analgesia nociception index
N/A

Detailed Description

Early recovery for patients undergoing surgery is the key factor for an outpatient procedure.

The technique of adding remifentanil to a local anesthesia is used in 22% of the procedures realized in The CHU de Caen Outpatient unit. Decreasing opioid dose, whose side effects are numerous and widely described, as well as reducing anxiety are daily challenges to ensure comfort and successful care.

We propose a prospective, randomized, monocentric, open label study to evaluate the impact of the use of an audiovisual distraction device on the intraoperative consumption of opioids, on the patient's pain and peroperative anxiety.

ANI (Analgesia Nociception Index) will be used for peroperative overall comfort measurement. We will analyze if audiovisual distraction can integrate existing techniques such as hypnosis.

Finally, we will also assess the medico-economic impact of this technique in order to establish a benefit / cost ratio.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
200 patients will be randomized. 100 patients operated on in vitro fertilization (50 patients in intervention group, 50 patients in active comparator group) 100 patients operated on venous access port placement (50 patients in intervention group, 50 patients in active comparator group)200 patients will be randomized. 100 patients operated on in vitro fertilization (50 patients in intervention group, 50 patients in active comparator group) 100 patients operated on venous access port placement (50 patients in intervention group, 50 patients in active comparator group)
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of an Immersive Audiovisual Distraction Device Impact on Peroperative Opioid Consumption. A Prospective Randomized Controlled Study
Actual Study Start Date :
Feb 19, 2020
Actual Primary Completion Date :
Jan 1, 2021
Actual Study Completion Date :
Jan 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Audiovisual distraction device

Audiovisual distraction device, analgesia nociception index monitoring, remifentanil added to local anesthesia technique

Device: Audiovisual distraction device
Evaluate the impact of an audiovisual distraction device on the peroperative opioid consumption

Device: Analgesia nociception index
ANI (Analgesia Nociception Index) will be used for peroperative overall comfort measurement

Active Comparator: Active comparator group

Analgesia nociception index monitoring, remifentanil added to local anesthesia technique

Device: Analgesia nociception index
ANI (Analgesia Nociception Index) will be used for peroperative overall comfort measurement

Outcome Measures

Primary Outcome Measures

  1. Intraoperative Remifentanil dose [1 hour]

    μg/kg/min

Secondary Outcome Measures

  1. Preoperative pain measured with a numeric pain rating scale (NRS) [1 hour]

    Numeric pain rating scale (0 = No pain to 10 = Worst pain imaginable)

  2. Preoperative anxiety measured by the Amsterdam Preoperative Anxiety and Information Scale (APAIS) [1 hour]

    APAIS measures the need-for-information with 6 items. Each one is rated from 1 = Not at all to 5 = Extremely. There is positive and significant correlation between the ned-for-information and anxiety.

  3. Preoperative anxiety measured by a visual analogue scale (VAS) [1 hour]

    Visual analogue scale is a 100mm horizontal line. At the left hand (0mm) the statement "not anxious at all" and at the right hand (100mm) the statement "most anxious I can imagine"

  4. Per operative Analgesia nociception index (ANI) value [1 hour]

    From 0 = Predominant sympathetic tone, pain and anxiety to 100 = Predominant parasympathetic tone, good analgesia. Negative linear Relationship between analgesia nociception index and pain scores

  5. Post operative anxiety measured by a visual analogue scale (VAS) [1 hour]

    Visual analogue scale is a 100mm horizontal line. At the left hand (0mm) the statement "not anxious at all" and at the right hand (100mm) the statement "most anxious I can imagine"

  6. Postoperative pain measured with a numeric pain rating scale (NRS) [1 hour]

    Numeric pain rating scale (0 = No pain to 10 = Worst pain imaginable)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adult patient

  • Signed consent

  • Outpatient surgery eligibility

  • Patient covered by social security

Exclusion Criteria:
  • Unsigned consent

  • Study participation refusal

  • Deafness, blindness

  • Claustrophobia

  • ANI contraindication (atrial fibrillation, pace maker, severe autonomic system dysfunction)

  • Contraindication or impossibility to use the audiovisual distraction device

Contacts and Locations

Locations

Site City State Country Postal Code
1 Caen University Hospital Caen Calvados France 14000

Sponsors and Collaborators

  • University Hospital, Caen

Investigators

  • Study Chair: Clément Buléon, MD, Caen UH

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital, Caen
ClinicalTrials.gov Identifier:
NCT04238572
Other Study ID Numbers:
  • 2019-A01243-54
First Posted:
Jan 23, 2020
Last Update Posted:
Aug 3, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Caen

Study Results

No Results Posted as of Aug 3, 2021